Sanfilippo Syndrome
Immunology
Prevalence
0.1 / 100K
3 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ta-ert | SPRUCE BIOSCIENCES, INC. (SPRB) |
BLA Filed(1)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| sls-005 | SEELOS THERAPEUTICS, INC. (SEEL) |
Compare drugs
Frequently asked questions
How many drugs are in development for Sanfilippo Syndrome?
BioSniper tracks 3 drugs in development for Sanfilippo Syndrome across 3 companies.
How many clinical trials target Sanfilippo Syndrome?
There are 3 clinical trials targeting Sanfilippo Syndrome tracked by BioSniper.
What is the prevalence of Sanfilippo Syndrome?
The estimated prevalence of Sanfilippo Syndrome is approximately 0.1 per 100,000 population.
Deep-dive into Sanfilippo Syndrome
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis